These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 31837989

  • 1. Favorable preservation of erectile function after prostate brachytherapy for localized prostate cancer.
    Bazinet A, Zorn KC, Taussky D, Delouya G, Liberman D.
    Brachytherapy; 2020; 19(2):222-227. PubMed ID: 31837989
    [Abstract] [Full Text] [Related]

  • 2. Erectile function after permanent prostate brachytherapy.
    Merrick GS, Butler WM, Galbreath RW, Stipetich RL, Abel LJ, Lief JH.
    Int J Radiat Oncol Biol Phys; 2002 Mar 15; 52(4):893-902. PubMed ID: 11958881
    [Abstract] [Full Text] [Related]

  • 3. Erectile function after prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Anderson RL, Kurko BS, Lief JH, Allen ZA.
    Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):437-47. PubMed ID: 15890585
    [Abstract] [Full Text] [Related]

  • 4. Long-term potency preservation following brachytherapy for prostate cancer.
    Snyder KM, Stock RG, Buckstein M, Stone NN.
    BJU Int; 2012 Jul 01; 110(2):221-5. PubMed ID: 22734475
    [Abstract] [Full Text] [Related]

  • 5. Erectile function durability following permanent prostate brachytherapy.
    Taira AV, Merrick GS, Galbreath RW, Butler WM, Wallner KE, Kurko BS, Anderson R, Lief JH.
    Int J Radiat Oncol Biol Phys; 2009 Nov 01; 75(3):639-48. PubMed ID: 19303721
    [Abstract] [Full Text] [Related]

  • 6. Effect of aging and long-term erectile function after iodine-125 prostate brachytherapy.
    Keyes M, Pickles T, Crook J, McKenzie M, Cheung A, Spadinger I, LaPointe V, Bachand WF, Morris J.
    Brachytherapy; 2015 Nov 01; 14(3):334-41. PubMed ID: 25684438
    [Abstract] [Full Text] [Related]

  • 7. Dose to the penile bulb and individual patient anatomy are predictive of erectile dysfunction in men treated with 125I low dose rate brachytherapy for localized prostate cancer.
    Chasseray M, Dissaux G, Bourbonne V, Boussion N, Goasduff G, Malloreau J, Malhaire JP, Fournier G, Tissot V, Pradier O, Valeri A, Schick U.
    Acta Oncol; 2019 Jul 01; 58(7):1029-1035. PubMed ID: 30761939
    [Abstract] [Full Text] [Related]

  • 8. The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction.
    Merrick GS, Butler WM, Wallner KE, Lief JH, Anderson RL, Smeiles BJ, Galbreath RW, Benson ML.
    Int J Radiat Oncol Biol Phys; 2002 Nov 15; 54(4):1055-62. PubMed ID: 12419431
    [Abstract] [Full Text] [Related]

  • 9. Proposal for a predictive model of erectile function after permanent (125)I prostate brachytherapy for localized prostate cancer.
    Huyghe E, Delaunay B, Njomnang Soh P, Delannes M, Walschaerts M, Delavierre D, Soulie M, Bachaud JM.
    Int J Impot Res; 2013 Nov 15; 25(4):121-6. PubMed ID: 23446806
    [Abstract] [Full Text] [Related]

  • 10. A prospective longitudinal survey of erectile dysfunction in patients with localized prostate cancer treated with permanent prostate brachytherapy.
    Matsushima M, Kikuchi E, Maeda T, Nakashima J, Sugawara A, Ando T, Mizuno R, Nagata H, Miyajima A, Shigematsu N, Oya M.
    J Urol; 2013 Mar 15; 189(3):1014-8. PubMed ID: 23017516
    [Abstract] [Full Text] [Related]

  • 11. Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer.
    Stock RG, Stone NN, Iannuzzi C.
    Int J Radiat Oncol Biol Phys; 1996 May 01; 35(2):267-72. PubMed ID: 8635932
    [Abstract] [Full Text] [Related]

  • 12. Favourable long-term outcomes with brachytherapy-based regimens in men ≤60 years with clinically localized prostate cancer.
    Kollmeier MA, Fidaleo A, Pei X, Cohen G, Zaider M, Mo Q, Cox B, Yamada Y, Zelefsky MJ.
    BJU Int; 2013 Jun 01; 111(8):1231-6. PubMed ID: 23551568
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the "Quadrella" at 3 years: New index to assess functional and oncological performance specific to prostate brachytherapy.
    Coquet JB, Delage F, Fourcade A, Callerot P, Goasduff G, Boussion N, Rousseau B, Serey-Eiffel S, Malhaire JP, Pradier O, Schick U, Fournier G, Valeri A.
    Brachytherapy; 2018 Jun 01; 17(5):782-787. PubMed ID: 29936129
    [Abstract] [Full Text] [Related]

  • 14. ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer.
    Rodda S, Tyldesley S, Morris WJ, Keyes M, Halperin R, Pai H, McKenzie M, Duncan G, Morton G, Hamm J, Murray N.
    Int J Radiat Oncol Biol Phys; 2017 Jun 01; 98(2):286-295. PubMed ID: 28433432
    [Abstract] [Full Text] [Related]

  • 15. Five-year potency preservation after iodine-125 prostate brachytherapy.
    Nishimura S, Yorozu A, Ohashi T, Sakayori M, Yagi Y, Nishiyama T, Saito S, Shiraishi Y, Yoshida K, Toya K, Shigematsu N.
    Int J Clin Oncol; 2014 Oct 01; 19(5):940-5. PubMed ID: 24170247
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of Baseline Erectile Dysfunction (ED) in an Australian Cohort of Men with Localized Prostate Cancer.
    Ong WL, McLachlan H, Millar JL.
    J Sex Med; 2015 May 01; 12(5):1267-74. PubMed ID: 25847707
    [Abstract] [Full Text] [Related]

  • 17. Subclinical inflammation as a predictor for erectile dysfunction after brachytherapy for localized prostate cancer.
    Garabed LR, Taussky D, Delouya G, Liberman D.
    Brachytherapy; 2022 May 01; 21(6):864-869. PubMed ID: 35879137
    [Abstract] [Full Text] [Related]

  • 18. Erectile function after brachytherapy with external beam radiation for prostate cancer.
    Fujioka H, Ishimura T, Sakai Y, Fujii T, Jo Y, Takenaka A, Fujisawa M.
    Arch Androl; 2004 May 01; 50(4):295-301. PubMed ID: 15277008
    [Abstract] [Full Text] [Related]

  • 19. Potency after permanent prostate brachytherapy for localized prostate cancer.
    Potters L, Torre T, Fearn PA, Leibel SA, Kattan MW.
    Int J Radiat Oncol Biol Phys; 2001 Aug 01; 50(5):1235-42. PubMed ID: 11483334
    [Abstract] [Full Text] [Related]

  • 20. Sexual potency preservation and quality of life after prostate brachytherapy and low-dose tadalafil.
    Pugh TJ, Mahmood U, Swanson DA, Munsell MF, Wang R, Kudchadker RJ, Bruno TL, Frank SJ.
    Brachytherapy; 2015 Aug 01; 14(2):160-5. PubMed ID: 25255712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.